Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Pubmed

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

The Lancet , Volume 397 (10269): 13 – Feb 1, 2021

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

The Lancet , Volume 397 (10269): 13 – Feb 1, 2021

Loading next page...
 
/lp/pubmed/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-UW0ZMO9DYw

References (20)

Copyright
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
eISSN
1474-547X
DOI
10.1016/S0140-6736(20)32661-1
pmid
33306989
Publisher site
See Article on Publisher Site

Abstract

Journal

The LancetPubmed

Published: Feb 1, 2021

There are no references for this article.